Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Aug;78(2):179-85.
doi: 10.1016/j.resuscitation.2008.01.028. Epub 2008 May 19.

Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial methods part 1: rationale and methodology for the impedance threshold device (ITD) protocol

Tom P Aufderheide  1 , Peter J Kudenchuk, Jerris R Hedges, Graham Nichol, Richard E Kerber, Paul Dorian, Daniel P Davis, Ahamed H Idris, Clifton W Callaway, Scott Emerson, Ian G Stiell, Thomas E Terndrup; ROC Investigators
Affiliations
Randomized Controlled Trial

Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial methods part 1: rationale and methodology for the impedance threshold device (ITD) protocol

Tom P Aufderheide et al. Resuscitation. 2008 Aug.

Abstract

Aim: The primary aim of this study is to compare survival to hospital discharge with a modified Rankin score (MRS)< or =3 between standard cardiopulmonary resuscitation (CPR) plus an active impedance threshold device (ITD) versus standard CPR plus a sham ITD in patients with out-of-hospital cardiac arrest. Secondary aims are to compare functional status and depression at discharge and at 3 and 6 months post-discharge in survivors.

Design: Prospective, double-blind, randomized, controlled, clinical trial.

Population: Patients with non-traumatic out-of-hospital cardiac arrest treated by emergency medical services (EMS) providers.

Setting: EMS systems participating in the Resuscitation Outcomes Consortium.

Sample size: Based on a one-sided significance level of 0.025, power=0.90, a survival with MRS< or =3 to discharge rate of 5.33% with standard CPR and sham ITD, and two interim analyses, a maximum of 14,742 evaluable patients are needed to detect a 6.69% survival with MRS< or =3 to discharge with standard CPR and active ITD (1.36% absolute survival difference).

Conclusion: If the ITD demonstrates the hypothesized improvement in survival, it is estimated that 2700 deaths from cardiac arrest per year would be averted in North America alone.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors of this manuscript have no conflicts of interest.

Figures

Figure 1
Figure 1. Description of Impedance Threshold Device
The ITD (Figure 1a) is designed to be inserted easily between a facemask or advanced airway (e.g., ET tube, Combitube, or LMA) and a manual resuscitation bag (Figure 1b). In addition to an advanced airway, the ITD can be attached to any pediatric or adult facemask (Figure 1c) taking care to provide a continuously tight seal around the nose and mouth during compressions and ventilations (Figure 1d). As such, the device can be easily used by rescuers trained at both basic and advanced life support levels and moved quickly from any facemask once the patient is intubated. The ITD contains ventilation timing assist lights, which flash at 10/minute at 1 second/flash to help promote the proper ventilation rate and duration for the patient with an advanced airway. For this trial, ITDs will be specially manufactured in an opaque color so that active (functional) and sham (non-functional placebo) devices will appear externally identical.
Figure 1
Figure 1. Description of Impedance Threshold Device
The ITD (Figure 1a) is designed to be inserted easily between a facemask or advanced airway (e.g., ET tube, Combitube, or LMA) and a manual resuscitation bag (Figure 1b). In addition to an advanced airway, the ITD can be attached to any pediatric or adult facemask (Figure 1c) taking care to provide a continuously tight seal around the nose and mouth during compressions and ventilations (Figure 1d). As such, the device can be easily used by rescuers trained at both basic and advanced life support levels and moved quickly from any facemask once the patient is intubated. The ITD contains ventilation timing assist lights, which flash at 10/minute at 1 second/flash to help promote the proper ventilation rate and duration for the patient with an advanced airway. For this trial, ITDs will be specially manufactured in an opaque color so that active (functional) and sham (non-functional placebo) devices will appear externally identical.
Figure 2
Figure 2. Outcomes for Patients Presenting with PEA
ROSC=Return of Spontaneous Circulation; 1 Hr=1-Hour Survival; ICU=ICU Admission Rate; 24 Hr=24 Hour Survival
Figure 3
Figure 3. Femoral Arterial Blood Pressure in Humans During CPR with ITD Use
See this image and copyright information in PMC

References

    1. Niemann JT. Cardiopulmonary resuscitation. N Engl J Med. 1992 Oct 8;327(15):1075–80. - PubMed
    1. Eisenberg MS, Horwood BT, Cummins RO, Reynolds-Haertle R, Hearne TR. Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med. 1990 Feb;19(2):179–86. - PubMed
    1. Becker LB, Ostrander MP, Barrett J, Kondos GT. Outcomes of CPR in a Large Metropolitan Area- Where are the Survivors? Ann Emerg Med. 1991;20(4):355–61. - PubMed
    1. Nichol G, Stiell IG, Laupacis A, Pham B, De Maio V, Wells GA. A Cumulative Metaanalysis Of The Effectiveness of Defibrillator-Capable Emergency Medical Services For Victims Of Out-Of-Hospital Cardiac Arrest. Ann Emerg Med. 1999;34(4):517–25. - PubMed
    1. Davis DP, Garberson LA, Andrusiek DL, Hostler D, Daya M, Pirrallo R, Craig A, Stephens S, Larsen J, Drum AF, Fowler R. A Descriptive Analysis of Emergency Medical Service Systems Participating in the Resuscitation Outcomes Consortium (ROC) Network. Prehosp Emerg Care. 2007 Oct-Dec;11(4):369–82. - PubMed

Publication types

MeSH terms